Neoadjuvant Chemoradiotherapy Followed by Esophagectomy with Three-Field Lymph Node Dissection for Thoracic Esophageal Squamous Cell Carcinoma Patients with Clinical Stage III and with Supraclavicular Lymph Node Metastasis

Neoadjuvant Chemoradiotherapy Followed by Esophagectomy with Three-Field Lymph Node Dissection for Thoracic Esophageal Squamous Cell Carcinoma Patients with Clinical Stage III and with Supraclavicular Lymph Node Metastasis

Background: Neoadjuvant chemoradiotherapy (NACRT) followed by esophagectomy is now the standard treatment for patients with resectable advanced thoracic esophageal squamous cell carcinoma (ESCC) worldwide. However, the efficacy of NACRT followed by esophagectomy with three-field lymph node dissectio...

Full description

Bibliographic Details
Main Authors: Yusuke Sato, Satoru Motoyama, Yuki Wada, Akiyuki Wakita, Yuta Kawakita, Yushi Nagaki, Kaori Terata, Kazuhiro Imai, Akira Anbai, Manabu Hashimoto, Yoshihiro Minamiya
Format: Article
Language:English
Published: MDPI AG 2021-02-01
Series:Cancers
Subjects:
esophageal cancer
esophageal squamous cell carcinoma
prognosis
neoadjuvant treatment
chemoradiotherapy
NACRT
Online Access:https://www.mdpi.com/2072-6694/13/5/983

Internet

https://www.mdpi.com/2072-6694/13/5/983

Similar Items